Data published elucidating a mechanism for the neuroprotective potential of pridopidine
Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced ...
May 25, 2022
0
85